Страна: Сингапур
Язык: английский
Источник: HSA (Health Sciences Authority)
AMIODARONE HCl
SANOFI-AVENTIS SINGAPORE PTE. LTD.
C01BD01
150 mg/3 ml
INJECTION
AMIODARONE HCl 150 mg/3 ml
INTRAVENOUS
Prescription Only
SANOFI WINTHROP INDUSTRIE
ACTIVE
1988-05-06
CORDARONE AMIODARONE HYDROCHLORIDE 150MG/3ML SOLUTION FOR INJECTION IN AMPOULES [SANOFI LOGO] COMPOSITION: Each 3ml ampoule contains 150mg amiodarone hydrochloride. PHARMACEUTICAL FORM Solution for injection. CLINICAL PARTICULARS THERAPEUTIC INDICATIONS Treatment should be initiated and normally monitored only under hospital or specialist supervision. Cordarone Intravenous is indicated only for the treatment of severe rhythm disorders not responding to other therapies or when other treatments cannot be used. Tachyarrhythmias associated with Wolff-Parkinson-White syndrome. All types of tachyarrhythmias including supraventricular, nodal and ventricular tachycardias; atrial flutter and fibrillation; ventricular fibrillation; when other drugs cannot be used. Cordarone Intravenous can be used where a rapid response is required or where oral administration is not possible. Cardiopulmonary resuscitation in the event of cardiac arrest related to ventricular fibrillation resistant to external electric shock. POSOLOGY AND METHOD OF ADMINISTRATION Cordarone Intravenous should only be used when facilities exist for cardiac monitoring, defibrillation, and cardiac pacing. Cordarone Intravenous may be used prior to DC cardioversion. The standard recommended dose is 5mg/kg bodyweight given by intravenous infusion over a period of 20 minutes to 2 hours. This should be administered as a dilute solution in 250ml 5% dextrose. This may be followed by repeat infusion up to 1200mg (approximately 15mg/kg bodyweight) in up to 500ml 5% dextrose per 24 hours, the rate of infusion being adjusted on the basis of clinical response. _(see Special _ _Warnings and Special Precautions for Use). _ In extreme clinical emergency the drug may, at the discretion of the clinician, be given as a slow injection of 150-300mg in 10-20ml 5% dextrose over a minimum of 3 minutes. This should not be repeated for at l Прочитать полный документ
Cordarone Amiodarone Hydrochloride 150mg/3ml Solution for injection in ampoules [sanofi logo] Composition: Each 3ml ampoule contains 150mg amiodarone hydrochloride. Pharmaceutical Form Solution for injection. Clinical Particulars Therapeutic Indications Treatment should be initiated and normally monitored only under hospital or specialist supervision. Cordarone Intravenous is indicated only for the treatment of severe rhythm disorders not responding to other therapies or when other treatments cannot be used. Tachyarrhythmias associated with Wolff-Parkinson-White syndrome. All types of tachyarrhythmias including supraventricular, nodal and ventricular tachycardias; atrial flutter and fibrillation; ventricular fibrillation; when other drugs cannot be used. Cordarone Intravenous can be used where a rapid response is required or where oral administration is not possible. Cardiopulmonary resuscitation in the event of cardiac arrest related to ventricular fibrillation resistant to external electric shock. Posology and Method of Administration Cordarone Intravenous should only be used when facilities exist for cardiac monitoring, defibrillation, and cardiac pacing. Cordarone Intravenous may be used prior to DC cardioversion. The standard recommended dose is 5mg/kg bodyweight given by intravenous infusion over a period of 20 minutes to 2 hours. This should be administered as a dilute solution in 250ml 5% dextrose. This may be followed by repeat infusion up to 1200mg (approximately 15mg/kg bodyweight) in up to 500ml 5% dextrose per 24 hours, the rate of infusion being adjusted on the basis of clinical response. (see Special Warnings and Special Precautions for Use). In extreme clinical emergency the drug may, at the discretion of the clinician, be given as a slow injection of 150-300mg in 10-20ml 5% dextrose over a minimum of 3 minutes. This should not be repeated for at least 15 minutes. Patients treated in this way with Cordarone Intravenous must be closely monitored, e.g. in an intensive care unit. (see Special Warning Прочитать полный документ